Canada - English - Health Canada

ranbaxy pharmaceuticals canada inc. - cefprozil (cefprozil monohydrate) - tablet - 250mg - cefprozil (cefprozil monohydrate) 250mg - second generation cephalosporins

Canada - English - Health Canada

ranbaxy pharmaceuticals canada inc. - cefprozil (cefprozil monohydrate) - tablet - 500mg - cefprozil (cefprozil monohydrate) 500mg - second generation cephalosporins

United States - English - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - cefprozil (unii: 4w0459za4v) (cefprozil anhydrous - unii:1m698f4h4e) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of cefprozil and other antibacterial drugs, cefprozil should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. cefprozil tablets are indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below: upper respiratory tract pharyngitis/tonsillitis caused by streptococcus pyogenes . note: the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever, is penicillin given by the intramuscular route. cefprozil is general

United States - English - NLM (National Library of Medicine)

a-s medication solutions - cefprozil (unii: 4w0459za4v) (cefprozil anhydrous - unii:1m698f4h4e) - cefprozil tablets are indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below: pharyngitis/tonsillitis caused by streptococcus pyogenes . note: the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever, is penicillin given by the intramuscular route. cefprozil is generally effective in the eradication of streptococcus pyogenes from the nasopharynx; however, substantial data establishing the efficacy of cefprozil in the subsequent prevention of rheumatic fever are not available at present. otitis media caused by streptococcus pneumoniae , haemophilus influenzae (including β-lactamase-producing strains), and moraxella (branhamella) catarrhalis (including β-lactamase-producing strains) (see clinical studies ). note: in the treatment of otitis media due to β-lactamase producing organisms, cefprozil had bacteriologic eradication

Canada - English - Health Canada

pro doc limitee - cefprozil (cefprozil monohydrate) - tablet - 500mg - cefprozil (cefprozil monohydrate) 500mg - second generation cephalosporins

Canada - English - Health Canada

sandoz canada incorporated - cefprozil - tablet - 250mg - cefprozil 250mg - second generation cephalosporins

Canada - English - Health Canada

sandoz canada incorporated - cefprozil - tablet - 500mg - cefprozil 500mg - second generation cephalosporins

Canada - English - Health Canada

sandoz canada incorporated - cefprozil (cefprozil monohydrate) - powder for suspension - 125mg - cefprozil (cefprozil monohydrate) 125mg - second generation cephalosporins

Canada - English - Health Canada

sandoz canada incorporated - cefprozil (cefprozil monohydrate) - powder for suspension - 250mg - cefprozil (cefprozil monohydrate) 250mg - second generation cephalosporins

United States - English - NLM (National Library of Medicine)

a-s medication solutions - cefprozil (unii: 4w0459za4v) (cefprozil anhydrous - unii:1m698f4h4e) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of cefprozil  and other antibacterial drugs, cefprozil should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. cefprozil for oral suspension is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below: upper respiratory tract pharyngitis/tonsillitis caused by streptococcus pyogenes . note: the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever, is penicillin given by the intramuscular route. cefprozil is generally effective in the eradication of streptococcus pyogenes from the nasopharynx; however, substantial data establishing the efficacy of cefprozil in the subsequent prevention of rheumatic fever are not available at present. otitis media caused by streptococcus pneumoniae , haemophilus influenzae (including β-lactamase-producing strains), and moraxella (branhamella) catarrhalis (including β-lactamase-producing strains). (see clinical studies .) note: in the treatment of otitis media due to β-lactamase producing organisms, cefprozil had bacteriologic eradication rates somewhat lower than those observed with a product containing a specific β-lactamase inhibitor. in considering the use of cefprozil, lower overall eradication rates should be balanced against the susceptibility patterns of the common microbes in a given geographic area and the increased potential for toxicity with products containing β-lactamase inhibitors. acute sinusitis caused by streptococcus pneumoniae , haemophilus influenzae (including β-lactamase-producing strains), and moraxella (branhamella) catarrhalis (including β-lactamase-producing strains). lower respiratory tract acute bacterial exacerbation of chronic bronchitis caused by streptococcus pneumoniae , haemophilus influenzae (including β-lactamase-producing strains), and moraxella (branhamella) catarrhalis (including β-lactamase-producing strains). skin and skin structure uncomplicated skin and skin-structure infections caused by staphylococcus aureus (including penicillinase-producing strains) and streptococcus pyogenes . abscesses usually require surgical drainage. cefprozil for oral suspension is contraindicated in patients with known allergy to the cephalosporin class of antibiotics.